Research

article-page-carousel-item--Advancements in NAD+ Research

Advancements in NAD+ Research

New research on NAD+ metabolism, NMN supplementation, and mitochondrial NAD+ levels was presented at the esteemed longevity conference, the Aging Research and Drug Discovery (ARDD) Meeting.

Advancements in NAD+ Research

New research on NAD+ metabolism, NMN supplementation, and mitochondrial NAD+ levels was presented at the esteemed...

article-page-carousel-item--Inhibition of CD38 Increases NAD+ Levels, Extends Life and Healthspan in Mice

Inhibition of CD38 Increases NAD+ Levels, Exten...

Two recent studies have found that inhibition of CD38 (with 78c or PCC1) increase NAD+ levels and result in significant increases in lifespan and healthspan in mice.

Inhibition of CD38 Increases NAD+ Levels, Exten...

Two recent studies have found that inhibition of CD38 (with 78c or PCC1) increase NAD+ levels...

article-page-carousel-item--Inhibition of CD38 Increases NAD+ Levels

Inhibition of CD38 Increases NAD+ Levels

Inhibition of CD38 Increases NAD+ and Extends Lifespan and Healthspan Two recent studies have found that inhibition of CD38 (with 78c or PCC1) increase NAD+ levels and result in significant...

Inhibition of CD38 Increases NAD+ Levels

Inhibition of CD38 Increases NAD+ and Extends Lifespan and Healthspan Two recent studies have found that...

article-page-carousel-item--Study Shows NMN Supplementation or CD38 Inhibition Restores Cardiovascular Function in Mice

Study Shows NMN Supplementation or CD38 Inhibit...

Declining NAD+ levels are a major contributor to cardiovascular disease in mice. It was demonstrated that raising NAD+ levels through NMN supplementation or by CD38 inhibition can restore cardiovascular function...

Study Shows NMN Supplementation or CD38 Inhibit...

Declining NAD+ levels are a major contributor to cardiovascular disease in mice. It was demonstrated that...